Weight-loss pill gets European approval recommendation
Most outlets reported the European Medicines Agency’s recommendation for Eli Lilly’s Foundayo weight-loss pill, noting it as the second oral obesity drug to receive such approval after Novo Nordisk’s. The framing was largely uniform, with a focus on the regulatory process and the pill’s status as a new treatment option in the region.
Summary generated by HarZaviya from the headlines and excerpts of the 2 outlets below. Each outlet's own headline is listed under it.
Same story from 2 outlets
Each outlet's own headline, most recent first — read any at its source.
-
Eli Lilly's Foundayo weight-loss pill gets European approval recommendation
The European Medicines Agency’s committee on Friday has recommended approval of Eli Lilly’s weight-loss pill Foundayo-the second oral obesity drug to gain the agency's approval after Novo Nordisk’s...
-
Foundayo: Weight-loss pill wins EU drug regulator’s backing
The recommendation will now be reviewed by the European Commission before it gives the final nod to launch the drug in the region....
2 articles from 2 outlets, 16 Oct–16 Oct 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?